Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR Long-Term Safety in Chronic Pain
NCT00361504Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tapentadol in osteoarthritis (OA), low back pain (LBP), sponsored by Johnson & Johnson. Started Nov 2006; status: completed.
02
Drugs
tapentadol
03
Conditions
osteoarthritis (OA)low back pain (LBP)
Beyond the preview
Go deeper on NCT00361504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361504.